weight plateau on tirzepatide Loss Stalled Tirzepatide? Why It Happens and How to Get Results Again GLP-1 Plateau: Causes & Solutions

Food and Drug Administration approved tirzepatide (Zepbound) injection for chronic weight management in adults with a BMI of 30 or with a BMI of 27 or greater with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol) this November

Insurance companies have largely classified Ozempic and other GLP-1 receptor agonists as upper-tier prescriptions, meaning that they typically provide less coverage for them

Polydeoxyribonucleotide gained traction alongside the global rise of K-beauty and South Korean dermatology

A new study states that Tirzepatide does not normally lead to lethargy

A 2025 systematic review in orthopedic sports medicine concluded that BPC-157 promotes healing by boosting growth factors and reducing inflammation, with improved structural and functional recovery across fracture, muscle, tendon, and ligament injury models

Feel free to order again when it's time for your next shot